We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+2.18%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$773M
AUM Growth
-$71.9M
Cap. Flow
-$78.8M
Cap. Flow %
-10.19%
Top 10 Hldgs %
77.44%
Holding
144
New
42
Increased
11
Reduced
17
Closed
69

Top Buys

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$11.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$10.8M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$10.8M
4
ARES icon
Ares Management
ARES
+$10.2M
5
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$10.2M

Top Sells

Rank Stock Value
1
BUD icon
AB InBev
BUD
+$16.4M
2
SN icon
SharkNinja
SN
+$14.8M
3
KSPI icon
Kaspi.kz JSC
KSPI
+$11.2M
4
ODD icon
ODDITY Tech
ODD
+$8.91M
5
GE icon
GE Aerospace
GE
+$8.43M

Sector Composition

Rank Sector Weight
1 Healthcare 6.59%
2 Technology 4.5%
3 Industrials 3.66%
4 Financials 3.35%
5 Consumer Discretionary 2.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TBBB icon
26
BBB Foods
TBBB
$4.92B
$3.94M 0.51%
165,000
-158,369
-49% -$3.71M
PWP icon
27
Perella Weinberg Partners
PWP
$1.3B
$3.77M 0.49%
232,076
-19,990
-8% -$302K
SMCI icon
28
Super Micro Computer
SMCI
$20.1B
$3.69M 0.48%
45,000
-15,000
-25% -$1.28M
VSEC icon
29
VSE Corp
VSEC
$6.12B
$3.61M 0.47%
+40,868
New +$3.28M
TEM
30
Tempus AI
TEM
$9.39B
$3.59M 0.46%
+102,604
New +$3.15M
ALKT icon
31
Alkami Technology
ALKT
$2.11B
$3.28M 0.42%
+115,000
New +$2.97M
GFS icon
32
GlobalFoundries
GFS
$29.6B
$3.26M 0.42%
+64,500
New +$3.23M
ROIV icon
33
Roivant Sciences
ROIV
$26.2B
$3.21M 0.41%
303,575
-46,425
-13% -$509K
DYN icon
34
Dyne Therapeutics
DYN
$4.9B
$3M 0.39%
85,000
-85,000
-50% -$2.47M
DAWN
35
DELISTED
Day One Biopharmaceuticals
DAWN
$2.76M 0.36%
+200,000
New +$2.93M
SLDB icon
36
Solid Biosciences
SLDB
$900M
$2.55M 0.33%
450,000
-170,000
-27% -$1.52M
LB
37
LandBridge Co
LB
$2.1B
$2.31M 0.3%
+100,000
New +$2.31M
CRGY icon
38
Crescent Energy
CRGY
$3.82B
$2.25M 0.29%
190,000
+14,900
+9% +$175K
MLTX icon
39
MoonLake Immunotherapeutics
MLTX
$1.55B
$2.2M 0.28%
50,000
-65,000
-57% -$2.75M
RXRX icon
40
Recursion Pharmaceuticals
RXRX
$1.73B
$2.17M 0.28%
+290,000
New +$2.53M
ULS icon
41
UL Solutions
ULS
$15.8B
$2.11M 0.27%
+49,980
New +$1.89M
GPGI
42
GPGI Inc
GPGI
$4.35B
$2.11M 0.27%
+373,240
New +$2.06M
RNAM
43
DELISTED
Avidity Biosciences
RNAM
$2.04M 0.26%
+50,000
New +$1.43M
GPCR icon
44
Structure Therapeutics
GPCR
$3.78B
$1.96M 0.25%
50,000
-44,714
-47% -$1.84M
PTON icon
45
Peloton Interactive
PTON
$2.49B
$1.86M 0.24%
+550,000
New +$1.97M
NVDA icon
46
NVIDIA
NVDA
$5.42T
$1.85M 0.24%
15,000
+5,000
+50% +$506K
REVG
47
DELISTED
REV Group
REVG
$1.62M 0.21%
65,000
-193,938
-75% -$4.76M
LPG icon
48
Dorian LPG
LPG
$1.96B
$1.36M 0.18%
+32,500
New +$1.4M
MSDL icon
49
Morgan Stanley Direct Lending Fund
MSDL
$1.3B
$1.36M 0.18%
62,315
-9,897
-14% -$220K
HUMA icon
50
Humacyte
HUMA
$194M
$1.34M 0.17%
280,000
-720,000
-72% -$3.75M
1
2
3 4 5

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Monashee Investment Management held 144 positions worth $773M, down 8.5% from $845M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Monashee Investment Management withdrew a net $78.8M in Q2 2024, closing 69 positions and reducing 17 holdings. Its most notable exit was AB InBev, an estimated $16.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 15% a quarter earlier, followed by Technology and Industrials.

Against the trend, Monashee Investment Management opened a new position in Ares Management worth $10M.

  • Monashee Investment Management's largest Q2 2024 buy was Ares Management: 75,000 shares worth $10M.
  • Monashee Investment Management added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $11.8M increase.
  • Monashee Investment Management's biggest Q2 2024 reduction was REV Group, cutting an estimated $4.76M.
  • Monashee Investment Management fully exited AB InBev in Q2 2024, selling an estimated $16.4M.
  • Monashee Investment Management's ten largest holdings make up 77% of its $773M portfolio in Q2 2024.
  • Monashee Investment Management opened 42 new positions and closed 69 in Q2 2024.
  • Monashee Investment Management's portfolio value fell 8.5% quarter-over-quarter to $773M.

Based on Monashee Investment Management's 13F filing for Q2 2024, filed 12 Aug 2024.